The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 431-440

  Funke, Verena ^a,b   Lehmann Koch, Judith ^a,b   Bickeböller, Michèle ^a,b   Benner, Axel ^b   Tagscherer, Katrin E ^a,b   Grund, Kerstin ^a,b   Pfeifer, Marco ^b   Herpel, Esther ^a   Schirmacher, Peter ^a   Chang Claude, Jenny ^b   Brenner, Hermann ^b   Hoffmeister, Michael ^b   Roth, Wilfried ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Colorectal carcinoma; Invasiveness; PEA 15 PED; Proliferation

Indexed keywords

ALPHAVBETA5 INTEGRIN; CISPLATIN; FLUOROURACIL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 KD; PHOSPHOPROTEIN ENRICHED IN DIABETES; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ABDOMINAL WALL; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CARCINOGENESIS; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME PHOSPHORYLATION; FEMALE; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; COLORECTAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLUOROURACIL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84878218410     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.053     Document Type: Article

References (53)

1. Condorelli G., Vigliotta G., Cafieri A., Trencia A., Andalo P., Oriente F., Miele C., Caruso M., Formisano P., Beguinot F. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 1999, 18:4409-4415.
2. Estelles A., Charlton C.A., Blau H.M. The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev. Biol. 1999, 216:16-28.
3. Hao C., Beguinot F., Condorelli G., Trencia A., Van Meir E.G., Yong V.W., Parney I.F., Roa W.H., Petruk K.C. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res. 2001, 61:1162-1170.
4. Kitsberg D., Formstecher E., Fauquet M., Kubes M., Cordier J., Canton B., Pan G., Rolli M., Glowinski J., Chneiweiss H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 1999, 19:8244-8251.
5. Condorelli G., Trencia A., Vigliotta G., Perfetti A., Goglia U., Cassese A., Musti A.M., Miele C., Santopietro S., Formisano P., Beguinot F. Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J. Biol. Chem. 2002, 277:11013-11018.
6. Formstecher E., Ramos J.W., Fauquet M., Calderwood D.A., Hsieh J.C., Canton B., Nguyen X.T., Barnier J.V., Camonis J., Ginsberg M.H., Chneiweiss H. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 2001, 1:239-250.
7. Krueger J., Chou F.L., Glading A., Schaefer E., Ginsberg M.H. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol. Biol. Cell 2005, 16:3552-3561.
8. Ramos J.W., Hughes P.E., Renshaw M.W., Schwartz M.A., Formstecher E., Chneiweiss H., Ginsberg M.H. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol. Biol. Cell 2000, 11:2863-2872.
9. Whitehurst A.W., Robinson F.L., Moore M.S., Cobb M.H. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J. Biol. Chem. 2004, 279:12840-12847.
10. Eckert A., Bock B.C., Tagscherer K.E., Haas T.L., Grund K., Sykora J., Herold-Mende C., Ehemann V., Hollstein M., Chneiweiss H., Wiestler O.D., Walczak H., Roth W. The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene 2008, 27:1155-1166.
11. Chou F.L., Hill J.M., Hsieh J.C., Pouyssegur J., Brunet A., Glading A., Uberall F., Ramos J.W., Werner M.H., Ginsberg M.H. PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J. Biol. Chem. 2003, 278:52587-52597.
12. Ramos J.W., Kojima T.K., Hughes P.E., Fenczik C.A., Ginsberg M.H. The death effector domain of PEA-15 is involved in its regulation of integrin activation. J. Biol. Chem. 1998, 273:33897-33900.
13. Stassi G., Garofalo M., Zerilli M., Ricci-Vitiani L., Zanca C., Todaro M., Aragona F., Limite G., Petrella G., Condorelli G. PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res. 2005, 65:6668-6675.
14. Renault-Mihara F., Beuvon F., Iturrioz X., Canton B., De Bouard S., Leonard N., Mouhamad S., Sharif A., Ramos J.W., Junier M.P., Chneiweiss H. Phosphoprotein enriched in astrocytes-15kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol. Biol. Cell 2006, 17:5141-5152.
15. Glading A., Koziol J.A., Krueger J., Ginsberg M.H. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 2007, 67:1536-1544.
16. Bartholomeusz C., Rosen D., Wei C., Kazansky A., Yamasaki F., Takahashi T., Itamochi H., Kondo S., Liu J., Ueno N.T. PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res. 2008, 68:9302-9310.
17. Bock B.C., Tagscherer K.E., Fassl A., Kramer A., Oehme I., Zentgraf H.W., Keith M., Roth W. The PEA-15 protein regulates autophagy via activation of JNK. J. Biol. Chem. 2010, 285:21644-21654.
18. Todaro M., Lombardo Y., Francipane M.G., Alea M.P., Cammareri P., Iovino F., Di Stefano A.B., Di Bernardo C., Agrusa A., Condorelli G., Walczak H., Stassi G. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ. 2008, 15:762-772.
19. Sharif A., Renault F., Beuvon F., Castellanos R., Canton B., Barbeito L., Junier M.P., Chneiweiss H. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 2004, 126:263-275.
20. Brenner H., Chang-Claude J., Seiler C.M., Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J. Clin. Oncol. 2011, 29:3761-3767.
21. Brattain M.G., Fine W.D., Khaled F.M., Thompson J., Brattain D.E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981, 41:1751-1756.
22. Leibovitz A., Stinson J.C., McCombs W.B., McCoy C.E., Mazur K.C., Mabry N.D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976, 36:4562-4569.
23. F. Castro, W.G. Dirks, S. Fahnrich, A. Hotz-Wagenblatt, M. Pawlita, M. Schmitt, High-throughput SNP-based authentication of human cell lines. Int. J. Cancer, 2012.
24. Schmitt M., Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucl. Acids Res. 2009, 37:e119.
25. Gillies R.J., Didier N., Denton M. Determination of cell number in monolayer cultures. Anal. Biochem. 1986, 159:109-113.
26. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
27. Danziger N., Yokoyama M., Jay T., Cordier J., Glowinski J., Chneiweiss H. Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J. Neurochem. 1995, 64:1016-1025.
28. Schemper M., Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin. Trials 1996, 17:343-346.
29. Putter H., Fiocco M., Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Statist. Med. 2007, 26:2389-2430.
30. A. Agresti, Categorical Data Analysis 2nd ed., John Wiley & Sons, Inc., Hoboken, New Jersey, 2002.
31. Araujo H., Danziger N., Cordier J., Glowinski J., Chneiweiss H. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 1993, 268:5911-5920.
32. Watanabe Y., Yamasaki F., Kajiwara Y., Saito T., Nishimoto T., Bartholomeusz C., Ueno N.T., Sugiyama K., Kurisu K. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis. J. Neurooncol. 2010, 100:449-457.
33. Dong G., Loukinova E., Chen Z., Gangi L., Chanturita T.I., Liu E.T., Van Waes C. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. Cancer Res. 2001, 61:4797-4808.
34. Formisano P., Perruolo G., Libertini S., Santopietro S., Troncone G., Raciti G.A., Oriente F., Portella G., Miele C., Beguinot F. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene 2005, 24:7012-7021.
35. Todaro M., Zerilli M., Ricci-Vitiani L., Bini M., Perez Alea M., Maria Florena A., Miceli L., Condorelli G., Bonventre S., Di Gesu G., De Maria R., Stassi G. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res. 2006, 66:1491-1499.
36. Bartholomeusz C., Gonzalez-Angulo A.M., Kazansky A., Krishnamurthy S., Liu P., Yuan L.X., Yamasaki F., Liu S., Hayashi N., Zhang D., Esteva F.J., Hortobagyi G.N., Ueno N.T. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin. Cancer Res. 2010, 16:1802-1811.
37. Kuramitsu Y., Miyamoto H., Tanaka T., Zhang X., Fujimoto M., Ueda K., Hamano K., Nakamura K. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines. Proteomics 2009, 9:5078-5089.
38. Hill J.M., Vaidyanathan H., Ramos J.W., Ginsberg M.H., Werner M.H. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 2002, 21:6494-6504.
39. Xiao C., Yang B.F., Asadi N., Beguinot F., Hao C. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 2002, 277:25020-25025.
40. Bartholomeusz C., Itamochi H., Nitta M., Saya H., Ginsberg M.H., Ueno N.T. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15. Oncogene 2006, 25:79-90.
41. Renganathan H., Vaidyanathan H., Knapinska A., Ramos J.W. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J. 2005, 390:729-735.
42. R. Buonomo, F. Giacco, A. Vasaturo, S. Caserta, S. Guido, V. Pagliara, C. Garbi, G. Mansueto, A. Cassese, G. Perruolo, F. Oriente, C. Miele, F. Beguinot, P. Formisano, PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms, J. Cell Physiol., 2011.
43. Condorelli G., Vigliotta G., Iavarone C., Caruso M., Tocchetti C.G., Andreozzi F., Cafieri A., Tecce M.F., Formisano P., Beguinot L., Beguinot F. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 1998, 17:3858-3866.
44. Vigliotta G., Miele C., Santopietro S., Portella G., Perfetti A., Maitan M.A., Cassese A., Oriente F., Trencia A., Fiory F., Romano C., Tiveron C., Tatangelo L., Troncone G., Formisano P., Beguinot F. Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol. Cell Biol. 2004, 24:5005-5015.
45. Incoronato M., Garofalo M., Urso L., Romano G., Quintavalle C., Zanca C., Iaboni M., Nuovo G., Croce C.M., Condorelli G. MiR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 2010, 70:3638-3646.
46. Zanca C., Garofalo M., Quintavalle C., Romano G., Acunzo M., Ragno P., Montuori N., Incoronato M., Tornillo L., Baumhoer D., Briguori C., Terracciano L., Condorelli G. PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J. Cell Mol. Med. 2008, 12:2416-2426.
47. Festuccia C., Gravina G.L., D'Alessandro A.M., Millimaggi D., Di Rocco C., Dolo V., Ricevuto E., Vicentini C., Bologna M. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Int. J. Oncol. 2008, 33:381-388.
48. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
49. Mizrak S.C., Renault-Mihara F., Parraga M., Bogerd J., van de Kant H.J., Lopez-Casas P.P., Paz M., del Mazo J., de Rooij D.G. Phosphoprotein enriched in astrocytes-15 is expressed in mouse testis and protects spermatocytes from apoptosis. Reproduction 2007, 133:743-751.
50. Formisano P., Ragno P., Pesapane A., Alfano D., Alberobello A.T., Rea V.E., Giusto R., Rossi F.W., Beguinot F., Rossi G., Montuori N. PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. J. Cell Mol. Med. 2012, 16:1435-1446.
51. Eyler C.E., Rich J.N. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol. 2008, 26:2839-2845.
52. Todaro M., Francipane M.G., Medema J.P., Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138:2151-2162.
53. Ricci-Vitiani L., Pagliuca A., Palio E., Zeuner A., De Maria R. Colon cancer stem cells. Gut 2008, 57:538-548.